Celebrities: study
Diabetes study seeks volunteers
PARKERSBURG - Local volunteers are being sought for a study on diabetes and depression. Program A.C.T.I.V.E. (Appalachians Coming Together to Increase Vital Exercise), funded through the National Institute of Diabetes and Digestive and Kidney Diseases, is a five-year study designed to test whether behavioral depression treatment with cognitive behavioral therapy and aerobic exercise results in [...]
Continue Reading
Healthy Diet Is Affordable, Study Shows
Consumers are firmly convinced that healthy food is more expensive than junk food. A new study published by the U.S. Department of Agriculture’s Economic Research Service says that might be because we are making the wrong comparisons. Andrew Carlson and Elizabeth Frazão turned to the USDA’s online guide, ChooseMyPlate, as a template for modeling a [...]
Continue Reading
Ceregene Parkinson’s disease study shows long-term neurturin expression and …
Ceregene Inc., a biotech company developing treatments for neurodegenerative diseases such as Parkinson’s disease, has presented new data demonstrating long-term, biologically-active expression of neurturin, a nervous system growth factor delivered to the degenerating dopamine nerves in patients with Parkinson’s disease following treatment with CERE-120 (AAV2-neurturin). Raymond T Bartus, Ceregene’s chief scientific officer and executive VP, [...]
Continue Reading
Clue to early diagnosis of pregnancy-related disease
Sydney, May 18: Doctors will now be able to identify early on whether a mother will develop pre-eclampsia, the most common and severe pregnancy-related disease, a study says.“It develops in mothers out of the blue, usually in the last three months of pregnancy, causing high blood pressure, kidney and liver damage and severe blood changes,” [...]
Continue Reading
Healthy eating can cost less, study finds
Is it really more expensive to eat healthy? An Agriculture Department study released Wednesday found that most fruits, vegetables and other healthy foods cost less than foods high in fat, sugar and salt. That counters a common perception among some consumers that it’s cheaper to eat junk food than a nutritionally balanced meal. The government [...]
Continue Reading
Good cholesterol may not cut heart attack risk
A new study has challenged a tenet of modern medicine that raising a person’s HDL - the so-called ‘good cholesterol’ - will necessarily lower the risk of a heart attack. The new research underscores the value of using genetic approaches to test biological hypotheses about human disease prior to developing specific drugs. A team led [...]
Continue Reading
Gene variants that speed progression of Parkinson’s disease identified
Washington, May 16 (ANI): A new discovery may hold the key to determine which Parkinson’s disease patients will experience a more rapid decline in motor function, sparking hopes for the development of new therapies and helping identify those who could benefit most from early intervention. In a study, UCLA researchers have found that Parkinson’s sufferers [...]
Continue Reading
Pregnancy-related disease`s warning sign `identified`
Melbourne: For the first time, scientists claim to have identified a sign which can indicate whether a mother-to-be would develop pre-eclampsia, the most common and severe pregnancy-related disease. A team at the University of Sydney says its findings may allow the early detection of pre-eclampsia which develops without warning and can do long-term damage to [...]
Continue Reading
Acupuncture may help some people with COPD: study
By Genevra Pittman NEW YORK | Wed May 16, 2020 2:58am IST NEW YORK (Reuters Health) - Three months of acupuncture improved breathing problems in people with chronic lung disease, in a new study from Japan. According to one researcher, the benefits seen with the alternative treatment were on par with, or better than, what’s [...]
Continue Reading
Roche Alzheimer’s drug picked for major test
By Julie Steenhuysen CHICAGO | Wed May 16, 2020 3:16am IST CHICAGO (Reuters) - Roche Holding AG’s Genentech unit has won the right to try its experimental Alzheimer’s drug crenezumab on people with no signs of dementia - the first such trial to gauge whether early intervention can help prevent or slow the disease. The [...]